These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 32526239

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
    Fritzinger DC, Hew BE, Thorne M, Pangburn MK, Janssen BJ, Gros P, Vogel CW.
    Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
    [Abstract] [Full Text] [Related]

  • 5. Structure and function of recombinant cobra venom factor.
    Kock MA, Hew BE, Bammert H, Fritzinger DC, Vogel CW.
    J Biol Chem; 2004 Jul 16; 279(29):30836-43. PubMed ID: 15131128
    [Abstract] [Full Text] [Related]

  • 6. Recombinant cobra venom factor.
    Vogel CW, Fritzinger DC, Hew BE, Thorne M, Bammert H.
    Mol Immunol; 2004 Jun 16; 41(2-3):191-9. PubMed ID: 15159065
    [Abstract] [Full Text] [Related]

  • 7. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
    Krishnan V, Ponnuraj K, Xu Y, Macon K, Volanakis JE, Narayana SV.
    Structure; 2009 Apr 15; 17(4):611-9. PubMed ID: 19368894
    [Abstract] [Full Text] [Related]

  • 8. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
    Fu Q, McPhie P, Gowda DC.
    Biochem Mol Biol Int; 1998 Jun 15; 45(1):133-44. PubMed ID: 9635137
    [Abstract] [Full Text] [Related]

  • 9. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
    Smith CA, Vogel CW, Müller-Eberhard HJ.
    J Biol Chem; 1982 Sep 10; 257(17):9879-82. PubMed ID: 6921201
    [Abstract] [Full Text] [Related]

  • 10. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
    Janssen BJ, Gomes L, Koning RI, Svergun DI, Koster AJ, Fritzinger DC, Vogel CW, Gros P.
    EMBO J; 2009 Aug 19; 28(16):2469-78. PubMed ID: 19574954
    [Abstract] [Full Text] [Related]

  • 11. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
    Vogel CW, Fritzinger DC.
    Curr Pharm Des; 2007 Aug 19; 13(28):2916-26. PubMed ID: 17979736
    [Abstract] [Full Text] [Related]

  • 12. Functional role of the noncatalytic subunit of complement C5 convertase.
    Rawal N, Pangburn MK.
    J Immunol; 2000 Feb 01; 164(3):1379-85. PubMed ID: 10640753
    [Abstract] [Full Text] [Related]

  • 13. Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.
    Laursen NS, Andersen KR, Braren I, Spillner E, Sottrup-Jensen L, Andersen GR.
    EMBO J; 2011 Feb 02; 30(3):606-16. PubMed ID: 21217642
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.
    von Zabern I, Hinsch B, Przyklenk H, Schmidt G, Vogt W.
    Immunobiology; 1980 Dec 02; 157(4-5):499-514. PubMed ID: 6905795
    [Abstract] [Full Text] [Related]

  • 15. Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis.
    Sharma S, Jabeen T, Singh RK, Bredhorst R, Vogel CW, Betzel C, Singh TP.
    Acta Crystallogr D Biol Crystallogr; 2001 Apr 02; 57(Pt 4):596-8. PubMed ID: 11264593
    [Abstract] [Full Text] [Related]

  • 16. Molecular cloning and derived primary structure of cobra venom factor.
    Fritzinger DC, Bredehorst R, Vogel CW.
    Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12775-9. PubMed ID: 7809120
    [Abstract] [Full Text] [Related]

  • 17. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
    Usami M, Ohno Y.
    J Pharmacol Toxicol Methods; 2005 Dec 20; 52(2):260-3. PubMed ID: 16125624
    [Abstract] [Full Text] [Related]

  • 18. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
    Kölln J, Matzas M, Jänner N, Mix T, Klensang K, Bredehorst R, Spillner E.
    Mol Immunol; 2004 May 20; 41(1):19-28. PubMed ID: 15140572
    [Abstract] [Full Text] [Related]

  • 19. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1984 Mar 20; 132(3):1425-9. PubMed ID: 6229580
    [Abstract] [Full Text] [Related]

  • 20. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
    Phipps D, Menger M, Chadwick JS, Aston WP.
    Dev Comp Immunol; 1987 Mar 20; 11(1):37-46. PubMed ID: 3647909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.